Mammography-detected cancers have better prognosis
|
Tweet
|
|
Breast cancers detected by mammographic screening have a better prognosis than those found outside of screening, even when other factors that influence disease outcome are the same, new research suggests. The reason for this association, however, is unclear.
In the study, breast tumors that were not detected by mammography were nearly twice as likely to recur at another site than cancers detected by mammographic screening. Because the choice of chemotherapy is based on the estimated risk of recurrence, the new findings could have treatment implications.
The results, published in the Journal of the American Medical Association, are based on a study of 2,842 women who were diagnosed with breast cancer in the early 1990s and logged in the Finnish Cancer Registry. The study focused on 1983 women with invasive cancer in one breast; 443 of these women had tumors detected by mammographic screening.
For all tumors, except those larger than 30 mm, detection by screening was linked to significantly better 10-year distant disease-free survival than detection outside of screening, lead author Dr. Heikki Joensuu, from Helsinki University Central Hospital, and colleagues note.
Specifically, tumors detected outside of mammography were 90 percent more likely to recur at another site compared with those detected by mammography.
Detection of breast cancers by mammography screening was a “favorable prognostic variable” the researcher conclude. This held true regardless of the number of positive lymph nodes, tumor size, patient age at diagnosis and the aggressiveness of the tumor, they add.
However, for tumors larger than 30 mm, survival did not vary based on detection method.
In a related editorial, Dr. Ruth M. O’Regan, from Emory University in Atlanta, comments that “it is not clear why patients whose tumors were detected by mammography screening had a better outcome, and it would be interesting to examine these tumors molecularly to determine if the differences between tumor detection modes can be delineated at a genetic level.”
SOURCE: Journal of the American Medical Association, September 1, 2004.
Revision date: June 11, 2011
Last revised: by Jorge P. Ribeiro, MD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Low vitamin D in diet increases stroke risk in Japanese-Americans
- Full Story - - »»»
Obesity not always tied to higher heart risk: study
- Full Story - - »»»
Scientists turn skin cells into beating heart muscle
- Full Story - - »»»
Too many people get angioplasties, study suggests
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

